Related Experiment Videos
[Prion diseases and blood transfusion]
P Beauvais1, T Billette de Villemeur
1Service de neuropédiatrie, hôpital Armand-Trousseau, Paris, France.
Summary
Prion diseases, fatal neuroinvasive disorders, may pose a theoretical blood transfusion risk, primarily linked to leukocytes. While the risk is mathematically very low, strict screening and donor exclusion are necessary.
Area of Science:
- Neurology
- Infectious Diseases
- Hematology
Background:
- Prion diseases are fatal and can be transmissible.
- Neuroinvasion suggests viremia during prion agent migration to the central nervous system.
- This raises concerns about potential transmission via blood products.
Purpose of the Study:
- To analyze experimental and epidemiological data on prion disease transmission via blood.
- To assess the transfusion risk associated with prion diseases.
- To inform blood donor policies and transfusion practices.
Main Methods:
- Review of experimental data on neuroinvasion and viremia.
- Analysis of epidemiological data related to prion disease transmission.
- Assessment of the theoretical risk of contamination from blood products.
Main Results:
- The risk of prion disease transmission via blood products is theoretically possible but mathematically very low.
- No indisputable experimental proof exists for systemic transmission.
- The risk appears linked to leukocytes, particularly B lymphocytes.
Conclusions:
- The transfusion risk from prion diseases is considered very low but not null.
- Conclusions are reassuring but necessitate ongoing epidemiological surveillance.
- Exclusion of certain individuals from blood donation is justified.